Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alarcón-Segovia D. Pathogenetic potential of antiphospholipid antibodies. J Rheumatol. 1988 Jun;15(6):890–893. [PubMed] [Google Scholar]
- Blum F., Gilkeson G., Greenberg C., Murray J. Superficial migratory thrombophlebitis and the lupus anticoagulant. Int J Dermatol. 1990 Apr;29(3):190–192. doi: 10.1111/j.1365-4362.1990.tb03797.x. [DOI] [PubMed] [Google Scholar]
- Harris E. N. Anticardiolipin antibodies and autoimmune diseases. Curr Opin Rheumatol. 1989 Aug;1(2):215–220. doi: 10.1097/00002281-198901020-00015. [DOI] [PubMed] [Google Scholar]
- Love P. E., Santoro S. A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990 May 1;112(9):682–698. doi: 10.7326/0003-4819-112-9-682. [DOI] [PubMed] [Google Scholar]
- Mackworth-Young C. G., Harris E. N., Steere A. C., Rizvi F., Malawista S. E., Hughes G. R., Gharavi A. E. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum. 1988 Aug;31(8):1052–1056. doi: 10.1002/art.1780310818. [DOI] [PubMed] [Google Scholar]
- Mitchell C. A., Rowell J. A., Hau L., Young J. P., Salem H. H. A fatal thrombotic disorder associated with an acquired inhibitor of protein C. N Engl J Med. 1987 Dec 24;317(26):1638–1642. doi: 10.1056/NEJM198712243172606. [DOI] [PubMed] [Google Scholar]
- Samlaska C. P., James W. D. Superficial thrombophlebitis. II. Secondary hypercoagulable states. J Am Acad Dermatol. 1990 Jul;23(1):1–18. doi: 10.1016/0190-9622(90)70179-l. [DOI] [PubMed] [Google Scholar]
- Santoro S. A. Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms. Blood. 1994 May 1;83(9):2389–2391. [PubMed] [Google Scholar]